Novozymes A/S (OTCMKTS:NVZMY) Shares Pass Below 200 Day Moving Average – Time to Sell?

Novozymes A/S (OTCMKTS:NVZMY)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $63.12 and traded as low as $56.37. Novozymes A/S shares last traded at $56.58, with a volume of 17,813 shares.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on NVZMY. Barclays raised shares of Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th. Berenberg Bank upgraded shares of Novozymes A/S to a “strong-buy” rating in a report on Tuesday, September 24th. Finally, Citigroup downgraded Novozymes A/S from a “neutral” rating to a “sell” rating in a research note on Thursday, October 17th.

Novozymes A/S Stock Down 0.0 %

The company has a 50 day moving average of $58.70 and a two-hundred day moving average of $63.10. The firm has a market cap of $26.49 billion, a P/E ratio of 35.80, a PEG ratio of 3.87 and a beta of 0.87.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.